Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 26, 2213-2217, October 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Roberts, J.
Right arrow Articles by Bachynsky, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Roberts, J.
Right arrow Articles by Bachynsky, N.

The Antitumor Activity of Escherichia coli L-Asparaginase1

Joseph Roberts, Morton D. Prager and Nicholas Bachynsky

Wadley Research Institute and Blood Bank and The Graduate Research Institute of Baylor University, Dallas, Texas

Two L-asparaginase components were isolated from Escherichia coli by diethylaminoethyl cellulose column chromatography. The early emerging component (Peak I L-asparaginase), capable of causing complete regression of the Gardner 6C3HED lymphosarcoma, exhibited optimum activity at pH 7.5–8.6 and was stable on prolonged incubation with C3H mouse serum or peritoneal ascitic fluid. In contrast, the Peak II L-asparaginase component exhibited optimum activity at about pH 8.5, was significantly inactivated on incubation with the mouse humoral fluids, and lacked tumor-inhibitory activity. A number of factors which may influence the therapeutic usefulness of enzymes are presented.

1 This publication was made possible through the support of the Leukemia Society, Inc.

Received 3/31/66.


This article has been cited by other articles:


Home page
ScienceHome page
G. E. Jones and R. K. Mortimer
L-Asparaginase-Deficient Mutants of Yeast
Science, January 9, 1970; 167(3915): 181 - 182.
[Abstract] [PDF]


Home page
ScienceHome page
B. Horowitz, B. K. Madras, A. Meister, L. J. Old, E. A. Boyse, and E. Stockert
Asparagine Synthetase Activity of Mouse Leukemias
Science, May 3, 1968; 160(3827): 533 - 535.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1966 by the American Association for Cancer Research.